{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corpus Christi",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "76235",
      "recalling_firm": "MOORE'S COMPOUNDING PHARMACY",
      "address_1": "5945 McArdle Rd Ste 101",
      "address_2": "N/A",
      "postal_code": "78412-3491",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "TX",
      "recall_number": "D-0488-2017",
      "product_description": "Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX",
      "product_quantity": "90 capsules",
      "reason_for_recall": "Superpotent Drug and Subpotent Drug; potency failures obtained",
      "recall_initiation_date": "20160912",
      "center_classification_date": "20170221",
      "termination_date": "20170517",
      "report_date": "20170301",
      "code_info": "2016-08-22:37@28, exp 2/18/2017"
    }
  ]
}